Clincosm LogoSign in Get a demo

ascvd

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

Not yet recruiting
  • Dyslipidemias
  • +4 more
  • Combination Therapy
  • +5 more
  • (no location specified)
Aug 22, 2023

ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial (Evolocumab,

Not yet recruiting
  • ASCVD
  • +3 more
  • (no location specified)
Aug 3, 2023

ASCVD, Coronary Artery Calcification Trial (Notification of patients and clinicians)

Not yet recruiting
  • ASCVD
  • Coronary Artery Calcification
  • Notification of patients and clinicians
  • (no location specified)
May 5, 2023

Type2Diabetes, ASCVD Trial (SGLT2 inhibitor, GLP-1 receptor agonist, Combination drug)

Recruiting
  • Type2Diabetes
  • ASCVD
  • SGLT2 inhibitor
  • +2 more
  • New York, New York
  • +1 more
Dec 19, 2022

Late Subclinical Cardiovascular Disease in Testicular Cancer

Recruiting
  • Testicular Cancer
  • +7 more
  • Lipid profile
  • +2 more
  • Indianapolis, Indiana
    Indiana University
Nov 7, 2022

Diabetes, Pre Diabetes, ASCVD Trial (high-intensity statin arm, low-intensity statin plus ezetimibe)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • high-intensity statin arm
  • low-intensity statin plus ezetimibe
  • (no location specified)
Oct 12, 2022

ASCVD, Elevated Cholesterol, Heterozygous Familial Hypercholesterolemia Trial in Worldwide (Inclisiran Sodium)

Active, not recruiting
  • ASCVD
  • +3 more
  • Inclisiran Sodium
  • Birmingham, Alabama
  • +237 more
Jan 26, 2022

Hyperlipemia, Mixed, ASCVD Trial in Boston (Alert)

Recruiting
  • Hyperlipemia, Mixed
  • ASCVD
  • Alert
  • Boston, Massachusetts
    Brigham and Women's Hospital
Oct 21, 2021

ASCVD Trial in Canada, United States

Terminated
  • ASCVD
    • Birmingham, Alabama
    • +163 more
    Oct 8, 2021

    ASCVD, Impaired Fasting Glucose, Hypertension Trial in Seongnam-si, Cheonan, Seoul (Duowell®, Monorova® + Amlopin®)

    Completed
    • ASCVD
    • +2 more
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +3 more
    May 31, 2021

    ASCVD, Elevated Cholesterol Trial in United States (Inclisiran Sodium, Placebo)

    Completed
    Has Results
    • ASCVD
    • Elevated Cholesterol
    • Inclisiran Sodium
    • Placebo
    • Birmingham, Alabama
    • +144 more
    Sep 8, 2020

    ASCVD, Risk Factor, Cardiovascular, Elevated Cholesterol Trial in Worldwide (Inclisiran Sodium, Placebo)

    Completed
    Has Results
    • ASCVD
    • +2 more
    • Inclisiran Sodium
    • Placebo
    • Chomutov, Czechia
    • +69 more
    Aug 3, 2020

    ASCVD Trial in Seongnam (Rosuvamibe, Monorova)

    Completed
    • ASCVD
    • Seongnam, Korea, Republic of
      Seoul National University Bundang Hospital
    Dec 27, 2019

    Metabolic Syndrome, ASCVD, Lifestyle Risk Reduction Trial in Fort Lauderdale (lifestyle modification)

    Unknown status
    • Metabolic Syndrome
    • +2 more
    • lifestyle modification
    • Fort Lauderdale, Florida
      Internal Medicine Residency Clinic at Holy Cross Hospital
    Sep 16, 2019

    Dyslipidemia, Subclinical hypothyroïdism, Statin Trial in Beijing (Pitavastatin and , Pitavastatin and levothyroxine)

    Unknown status
    • Dyslipidemia
    • +3 more
    • Pitavastatin and placebo
    • Pitavastatin and levothyroxine
    • Beijing, China
      Fuwai Hospital, China National Center for Cardiovascular Disease
    Mar 18, 2019